HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[3rd Hungarian Breast Cancer Consensus Conference - Radiotherapy Guidelines].

Abstract
The radiotherapy expert panel revised and updated the radiotherapy (RT) guidelines accepted in 2009 at the 2nd Hungarian Breast Cancer Consensus Conference based on new scientific evidence. Radiotherapy of the conserved breast is indicated in ductal carcinoma in situ (St. 0), as RT decreases the risk of local recurrence by 60%. In early stage (St. I-II) invasive breast cancer RT remains a standard treatment following breast conserving surgery. However, in elderly (≥70 years) patients with stage I, hormone receptor positive tumour hormonal therapy without RT can be considered. Hypofractionated (15×2.67 Gy) whole breast irradiation and for selected cases accelerated partial breast irradiation are validated treatment alternatives of conventional (25×2 Gy) whole breast irradiation. Following mastectomy RT significantly decreases the risk of locoregional recurrence and improves overall survival of patients having 1 to 3 (pN1a) or ≥4 (pN2a, pN3a) positive axillary lymph nodes. In selected cases of patients with 1 to 2 positive sentinel lymph nodes axillary dissection can be omitted and substituted with axillary RT. After neoadjuvant chemotherapy (NAC) followed by breast conserving surgery whole breast irradiation is mandatory, while after NAC followed by mastectomy locoregional RT should be given in cases of initial stage III-IV and ypN1 axillary status.
AuthorsCsaba Polgár, Zsuzsanna Kahán, András Csejtei, Gabriella Gábor, László Landherr, László Mangel, Árpád Mayer, János Fodor
JournalMagyar onkologia (Magy Onkol) Vol. 60 Issue 3 Pg. 229-39 (09 2016) ISSN: 0025-0244 [Print] Hungary
Vernacular TitleIII. Emlõrák Konszenzus Konferencia - Sugárterápiás irányelvek.
PMID27579722 (Publication Type: Consensus Development Conference, Journal Article)
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Breast Neoplasms (therapy)
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Mastectomy
  • Mastectomy, Segmental
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Radiotherapy, Adjuvant

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: